Gladstone in the News

The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.

HIV Prevention Pill Truvada Does Not Lead to Sexual Risk-taking
December 18, 2013

The HIV prevention drug Truvada does not increase risky sexual behaviour, scientists have confirmed.

Taking Drug to Prevent HIV Doesn't Seem to Encourage Risk-Taking
December 18, 2013

Should people in danger of contracting HIV because they have risky sex take a pill to prevent infection, or will the medication encourage them to take even more sexual risks? After years of debate on this question, a new international study suggests the medication doesn't lead people to stop using condoms or have more sex with more people.

New Approach To Alzheimer's Treatment Offers Hope
December 11, 2013

Health research backer Wellcome Trust awarded Dr. Robert Mahley of the Gladstone Institutes its Seeding Drug Discovery Award on Monday. The $2.5 million grant gives Mahley’s team three years to develop its novel approach to treating Alzheimer’s disease.

Molecular Sensor Finds Early Signs of Multiple Sclerosis in the Brain
December 11, 2013

Researchers at Gladstone Institutes in San Francisco have created a molecular sensor that can detect multiple sclerosis (MS) early. The method is so precise that MS can be tracked long before disease onset when a patient first presents with symptoms. 

Gladstone founder wins grant for new approach to Alzheimer's drug
December 9, 2013

A $2.5 million grant to Gladstone Institutes senior investigator and founder Robert Mahley could help lay a new course toward an Alzheimer's disease treatment.

Sustainable Science to Promote Health in Africa
December 3, 2013

Gladstone postdoctoral fellow Stefanie Sowinski is featured in an article and video about her work in Uganda, where she helps train a new generation of African researchers in the use of science to overcome HIV/AIDS.

To truly address the HIV/AIDS pandemic, the global community must refocus on a cure and a vaccine
December 1, 2013

In an op-ed on World AIDS Day, Gladstone's Warner C. Greene outlines the dangers of a new disease known as AIDS fatigue—and suggests a course of action for its treatement.

AIDS has become manageable in the minds of many
November 30, 2013

In a San Francisco radio broadcast, Gladstone's Warner C. Greene asks the local community to once again take the lead against HIV/AIDS—this time to fight against misconceptions about our era's deadliest epidemic.


Breakthrough discoveries: how iPS cells are changing stem cell science
November 19, 2013

Shinya Yamanaka, who won the Nobel Prize last year and who bridges two countries with labs at Kyoto University and the Gladstone Institutes in San Francisco, was honored when the Japan-based Alliance Forum Foundation brought its meeting to San Francisco last Friday. Throughout the day Yamanaka’s prize-winning idea for reprogramming adult cells into embryonic-like stem cells was referred to as game changing for all of biology.

 

Researchers dig deeper for Alzheimer's cure
November 19, 2013

The pressure to find treatments and preventions for Alzheimer's disease has been building steadily over the past decade, and it's becoming critical as the United States prepares for the crush of Baby Boomers who are approaching their 70s, when the disease is most likely to strike.